<DOC>
	<DOCNO>NCT01344941</DOCNO>
	<brief_summary>The primary objective study - Define envelope-specific B-cell T-cell response human receive St. Jude HIV-1 vaccine . - Describe mechanisms HIV-1 envelope process consequent B-cell T-cell activity .</brief_summary>
	<brief_title>Human Immune Responses Toward HIV-1 Envelope Antigens</brief_title>
	<detailed_description>The goal protocol understand human lymphocytes respond HIV-1 antigen context vaccination infection . This protocol support understand immune response provide source lymphocyte serum select individual study laboratory base investigation . Blood samples individual receive HIV-1 vaccine , individual HIV-1-infected , individual HIV-1-uninfected request : ( 1 ) test previously vaccinate volunteer HIV-1 envelope-specific B-cell T-cell immune activity , ( 2 ) increase understand human immune system process respond HIV-1 envelope protein .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Participant great equal 18 year age . Participant good general health . Participant weigh â‰¥ 110 pound . Participant hemoglobin &gt; 12 gm/dL within last 12 week . Group 1 ( Vaccinees ) Participant previously receive one St. Jude HIV1 vaccine via enrollment prior St. Jude HIV vaccine study . Group 2 ( HIV positive ) Participant HIV1 positive medical record review . Group 3 ( HIV negative ) Participant HIV1 negative determine HIV ELISA . Participant unable unwilling give write informed consent . Participant pregnant female . Group 2 ( HIV positive ) Participant enrol clinical trial include blood sample cumulative blood draw would exceed establish constitute minimal risk ( e.g. , 550 ml 8 week period collection frequently 2 time per week )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Vaccine response</keyword>
	<keyword>Human Lymphocytes</keyword>
</DOC>